The Medicaid Drug Rebate Program (MDRP) is a partnership between CMS, state Medicaid agencies, and participating drug manufacturers that helps to significantly offset the Federal and state costs of covered outpatient prescription drugs dispensed to Medicaid recipients. It is estimated that 45-50% of total Medicaid program expenditures on covered outpatient drugs are returned in the form of Federal and state supplemental rebates. Approximately 600 drug manufacturers currently participate in this program. All 50 states and the District of Columbia cover prescription drugs under the MDRP.
Drug rebate administration is a complex task involving claim identification, adjustment reconciliation, invoicing, collection, application of accrued interest and financial reporting. Given this complexity, there are many areas of risk for state Medicaid programs to lose significant rebate revenue due to errors in rebate administration and accounting. As a Certified Public Accounting (CPA) firm with more than 37 years of working with state Medicaid programs, Myers and Stauffer is uniquely positioned to review and audit all policy and accounting activities for your state’s MDRP.
Delivery Systems and Medicaid Drug Rebate Availability
Common Areas of Deficiencies and Opportunities in Drug Rebate Administration
For More Information
We encourage you to contact Lynsey Plew by email at email@example.com to arrange a discussion or meeting for more information regarding drug rebate performance auditing and consultation services, or to answer any general questions.